Second Quarter 2023 Highlights
- Sales of $2.0 billion, down 22% year over year, up 1% organically year over year, up 3% from prior quarter
- Net income of $59 million, or $0.58 per share, compared with $114 million, or $1.05 per share, in second quarter 2022
- Adjusted EBITDA of $198 million, up 10% from second quarter 2022 on a comparable basis excluding Russian Operations
PITTSBURGH–(BUSINESS WIRE)–Arconic Corporation (NYSE: ARNC) (“Arconic” or the “Company”) today reported second quarter 2023 results. Sales were $2.0 billion, down 22% year over year due to lower aluminum prices and the divestiture of Russian Operations and up 1% organically driven by strength in aerospace and ground transportation offset by declines in industrial, packaging, and building and construction. The Company reported net income of $59 million, or $0.58 per share, compared with $114 million, or $1.05 per share, in second quarter 2022.
Second quarter 2023 Adjusted EBITDA was $198 million, up 10% year over year on a comparable basis excluding Russian Operations. Cash provided from operations was $189 million and capital expenditures were $57 million.
Second Quarter Segment Performance
Sales by Segment (in millions)
|
|
Quarter ended |
|||||||||||
|
|
June 30, 2023 |
June 30, 2022 |
||||||||||
|
|
As reported |
As reported |
Russia |
As recast |
||||||||
|
Rolled Products |
$ |
1,529 |
|
$ |
2,113 |
|
$ |
314 |
|
$ |
1,799 |
|
|
Building and Construction Systems |
|
319 |
|
|
329 |
|
|
– |
|
|
329 |
|
|
Extrusions |
|
125 |
|
|
105 |
|
|
– |
|
|
105 |
|
Adjusted EBITDA (in millions)
|
|
Quarter ended |
|||||||||||
|
|
June 30, 2023 |
June 30, 2022 |
||||||||||
|
|
As reported |
As reported |
Russia |
As recast |
||||||||
|
Rolled Products |
$ |
158 |
|
$ |
174 |
|
$ |
24 |
|
$ |
150 |
|
|
Building and Construction Systems |
|
53 |
|
|
53 |
|
|
– |
|
|
53 |
|
|
Extrusions |
|
(1 |
) |
|
(12 |
) |
|
– |
|
|
(12 |
) |
|
Subtotal |
|
210 |
|
|
215 |
|
|
24 |
|
|
191 |
|
|
Corporate |
|
(12 |
) |
|
(11 |
) |
|
– |
|
|
(11 |
) |
|
Adjusted EBITDA |
$ |
198 |
|
$ |
204 |
|
$ |
24 |
|
$ |
180 |
|
About Arconic
Arconic Corporation (NYSE: ARNC), headquartered in Pittsburgh, Pennsylvania, is a leading provider of aluminum sheet, plate, and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, building and construction, industrial and packaging end markets. For more information: www.arconic.com.
Dissemination of Company Information
Arconic intends to make future announcements regarding Company developments and financial performance through its website at www.arconic.com.
Forward-Looking Statements
This release contains statements that relate to future events and expectations and, as such, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those containing such words as “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “guidance,” “intends,” “may,” “outlook,” “plans,” “projects,” “seeks,” “sees,” “should,” “targets,” “will,” “would,” or other words of similar meaning. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements, relating to the condition of, or trends or developments in, the ground transportation, aerospace, building and construction, industrial, packaging and other end markets; the Company’s future financial results, operating performance, working capital, cash flows, liquidity and financial position; cost savings and restructuring programs; the Company’s strategies, outlook, business and financial prospects; share repurchases; costs associated with pension and other post-retirement benefit plans; projected sources of cash flow; potential legal liability; the impact of inflationary price pressures; and the potential impact of public health epidemics or pandemics, including the COVID-19 pandemic. These statements reflect beliefs and assumptions that are based on the Company’s perception of historical trends, current conditions and expected future developments, as well as other factors the Company believes are appropriate in the circumstances. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those indicated by these forward-looking statements due to a variety of risks, uncertainties and changes in circumstances, many of which are beyond the Company’s control. Such risks and uncertainties include, but are not limited to: (i) continuing uncertainty regarding the impact of the COVID-19 pandemic on our business and the businesses of our customers and suppliers; (ii) deterioration in global economic and financial market conditions generally; (iii) unfavorable changes in the end markets we serve; (iv) the inability to achieve the level of revenue growth, cash generation, cost savings, benefits of our management of legacy liabilities, improvement in profitability and margins, fiscal discipline, or strengthening of competitiveness and operations anticipated or targeted; (v) adverse changes in discount rates or investment returns on pension assets; (vi) competition from new product offerings, disruptive technologies, industry consolidation or other developments; (vii) the loss of significant customers or adverse changes in customers’ business or financial condition; (viii) manufacturing difficulties or other issues that impact product performance, quality or safety or timely delivery; (ix) the impact of pricing volatility in raw materials and inflationary pressures on our costs of production, including energy; (x) a significant downturn in the business or financial condition of a key supplier or other supply chain disruptions; (xi) challenges to or infringements on our intellectual property rights; (xii) the inability to successfully implement or to realize the expected benefits of strategic initiatives or projects; (xiii) the inability to identify or successfully respond to changing trends in our end markets; (xiv) the impact of potential cyber attacks and information technology or data security breaches; (xv) geopolitical, economic, and regulatory risks relating to our global operations, including compliance with U.S. and foreign trade and tax laws and other regulations, potential expropriation of properties located outside the U.S., sanctions, tariffs, embargoes, and renegotiation or nullification of existing agreements; (xvi) the outcome of contingencies, including legal proceedings, government or regulatory investigations, and environmental remediation and compliance matters; (xvii) the impact of the ongoing conflict between Russia and Ukraine on economic conditions in general and on our business and operations, including sanctions, tariffs, and increased energy prices; (xviii) the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction that could reduce anticipated benefits or cause the parties to abandon the proposed transaction; (xix) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into pursuant to the proposed transaction; (xx) the risk that the parties to the merger agreement may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; (xxi) risks related to disruption of management time from ongoing business operations due to the proposed transaction; (xxii) the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of the Company’s common stock; (xxiii) the risk of any unexpected costs or expenses resulting from the proposed transaction; (xxiv) the risk of any litigation relating to the proposed transaction; (xxv) the risk that the proposed transaction and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, employees, stockholders and other business relationships and on its operating results and business generally; and (xxvi) the other risk factors summarized in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and other documents filed by the Company with the SEC. The above list of factors is not exhaustive or necessarily in order of importance. Market projections are subject to the risks discussed above and in this release, and other risks in the market. The statements in this release are made as of the date set forth above, even if subsequently made available by the Company on its website or otherwise. The Company disclaims any intention or obligation to update any forward-looking statements, whether in response to new information, future events, or otherwise, except as required by applicable law.
Non-GAAP Financial Measures
Some of the information included in this release is derived from Arconic’s consolidated financial information but is not presented in Arconic’s financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Certain of these financial measures are considered “non-GAAP financial measures” under SEC rules. These non-GAAP financial measures supplement our GAAP disclosures and should not be considered an alternative to any measure of performance or financial condition as determined in accordance with GAAP, and investors should consider Arconic’s performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of Arconic. Non-GAAP financial measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the results or financial condition as reported under GAAP. Non-GAAP financial measures presented by Arconic may not be comparable to non-GAAP financial measures presented by other companies. Reconciliations to the most directly comparable GAAP financial measures and management’s rationale for the use of the non-GAAP financial measures can be found in the schedules to this release.
|
Arconic Corporation and subsidiaries |
||||||||||
|
Statement of Consolidated Operations (unaudited) |
||||||||||
|
(dollars in millions, except per-share amounts) |
||||||||||
|
|
|
Quarter ended |
||||||||
|
|
|
June 30, |
|
March 31, |
|
June 30, |
||||
|
2023 |
2023 |
2022 |
||||||||
|
Sales |
|
$ |
1,990 |
|
$ |
1,929 |
|
$ |
2,548 |
|
|
Cost of goods sold (exclusive of expenses below)(1) |
|
|
1,724 |
|
|
1,724 |
|
|
2,258 |
|
|
Selling, general administrative, and other expenses |
|
|
79 |
|
|
72 |
|
|
73 |
|
|
Research and development expenses |
|
|
9 |
|
|
9 |
|
|
9 |
|
|
Provision for depreciation and amortization |
|
|
52 |
|
|
53 |
|
|
62 |
|
|
Restructuring and other charges(2) |
|
|
9 |
|
|
— |
|
|
2 |
|
|
Operating income |
|
|
117 |
|
|
71 |
|
|
144 |
|
|
Interest expense |
|
|
25 |
|
|
25 |
|
|
26 |
|
|
Other expenses (income), net(3) |
|
|
16 |
|
|
11 |
|
|
(35 |
) |
|
Income before income taxes |
|
|
76 |
|
|
35 |
|
|
153 |
|
|
Provision for income taxes |
|
|
17 |
|
|
10 |
|
|
38 |
|
|
Net income |
|
|
59 |
|
|
25 |
|
|
115 |
|
|
Less: Net income attributable to noncontrolling interest(4) |
|
|
— |
|
|
— |
|
|
1 |
|
|
NET INCOME ATTRIBUTABLE TO ARCONIC CORPORATION |
|
$ |
59 |
|
$ |
25 |
|
$ |
114 |
|
|
|
|
|
|
|
|
|
||||
|
EARNINGS PER SHARE ATTRIBUTABLE TO ARCONIC CORPORATION COMMON STOCKHOLDERS: |
|
|
|
|
|
|
||||
|
Basic: |
|
|
|
|
|
|
||||
|
Net income |
|
$ |
0.59 |
|
$ |
0.25 |
|
$ |
1.08 |
|
|
Weighted-average number of shares |
|
|
100,129,944 |
|
|
99,408,330 |
|
|
105,650,970 |
|
|
Diluted: |
|
|
|
|
|
|
||||
|
Net income |
|
$ |
0.58 |
|
$ |
0.24 |
|
$ |
1.05 |
|
|
Weighted-average number of shares(5) |
|
|
102,101,982 |
|
|
102,084,961 |
|
|
108,044,957 |
|
|
COMMON STOCK OUTSTANDING AT THE END OF THE PERIOD |
|
|
100,343,437 |
|
|
99,424,955 |
|
|
104,499,058 |
|
|
__________________ |
|
|
(1) |
In the quarter ended March 31, 2023, Arconic recorded both a $74 charge and a $74 benefit in Cost of goods sold to establish a liability for a settlement in principle and a receivable for insurance reimbursement, respectively, related to a litigation matter. |
|
|
On May 14, 2022, the Company and the United Steelworkers reached a tentative four-year labor agreement covering approximately 3,300 employees at four U.S. locations; the previous labor agreement expired on May 15, 2022. The tentative agreement was ratified by the union employees on June 1, 2022. In the quarter ended June 30, 2022, Arconic recognized $19 in Cost of goods sold primarily for a one-time signing bonus for the covered employees. |
|
(2) |
On May 4, 2023, Arconic entered into an Agreement and Plan of Merger to be acquired by funds managed by affiliates of Apollo Global Management, Inc., as well as a minority investment from funds managed by affiliates of Irenic Capital Management LP. The transaction is expected to close in the second half of 2023, subject to customary closing conditions, including approval by the Company’s stockholders. Accordingly, in the quarter ended June 30, 2023, Restructuring and other charges includes $11 for costs incurred related to the proposed merger. |
|
(3) |
In the quarter ended June 30, 2022, Other income, net includes a $54 gain for the remeasurement of monetary balances, primarily cash, related to the Company’s former operations in Russia from rubles to the U.S. dollar. This gain was the result of a significant strengthening of the Russian ruble against the U.S. dollar in the period. |
|
(4) |
On November 15, 2022, Arconic completed the sale of 100% of its operations in Russia to Promishlennie Investitsii LLC, the majority owner of VSMPO-AVISMA Corporation, for cash proceeds of $230. The transaction closed after the Company received all required approvals, resulting in the receipt of the cash consideration in exchange for all of Arconic’s net assets in Russia. These net assets included $203 of cash held in Russia that was not available for distribution to the parent company because of injunctions imposed as a result of litigation initiated in March 2020 by the Federal Antimonopoly Service of The Russian Federation (“FAS”). The Company recorded a loss of $306 ($304 after-tax) in the fourth quarter of 2022 in connection with this transaction. At a hearing on December 22, 2022, the Samara Court dismissed the litigation. |
|
|
Prior to the sale of Arconic’s operations in Russia, VSMPO-AVISMA Corporation owned a limited portion of one of the legal entities included in the sale. VSMPO-AVISMA Corporation’s share of net income (loss) of this legal entity was reported in this line item. Subsequent to the sale, there is no longer a noncontrolling interest in Arconic Corporation and its subsidiaries. |
|
(5) |
For periods in which the Company generates net income, the diluted weighted-average number of shares include common share equivalents associated with outstanding employee stock awards. For periods in which the Company generates a net loss, the diluted weighted-average number of shares does not include any common share equivalents as their effect is anti-dilutive. |
|
Arconic Corporation and subsidiaries |
||||||||
|
Consolidated Balance Sheet (unaudited) |
||||||||
|
(in millions) |
||||||||
|
|
|
June 30, |
|
December 31, |
||||
|
2023 |
2022 |
|||||||
|
ASSETS |
|
|
|
|
||||
|
Current assets: |
|
|
|
|
||||
|
Cash and cash equivalents |
|
$ |
266 |
|
|
$ |
261 |
|
|
Receivables from customers, less allowances of $2 in 2023 and $1 in 2022 |
|
|
907 |
|
|
|
791 |
|
|
Other receivables |
|
|
138 |
|
|
|
183 |
|
|
Inventories |
|
|
1,544 |
|
|
|
1,622 |
|
|
Fair value of hedging instruments and derivatives |
|
|
56 |
|
|
|
21 |
|
|
Prepaid expenses and other current assets(1) |
|
|
158 |
|
|
|
124 |
|
|
Total current assets |
|
|
3,069 |
|
|
|
3,002 |
|
|
Properties, plants, and equipment |
|
|
7,037 |
|
|
|
6,957 |
|
|
Less: accumulated depreciation and amortization |
|
|
4,688 |
|
|
|
4,596 |
|
|
Properties, plants, and equipment, net |
|
|
2,349 |
|
|
|
2,361 |
|
|
Goodwill |
|
|
294 |
|
|
|
292 |
|
|
Operating lease right-of-use-assets |
|
|
110 |
|
|
|
115 |
|
|
Deferred income taxes |
|
|
170 |
|
|
|
188 |
|
|
Other noncurrent assets |
|
|
54 |
|
|
|
57 |
|
|
Total assets |
|
$ |
6,046 |
|
|
$ |
6,015 |
|
|
LIABILITIES |
|
|
|
|
||||
|
Current liabilities: |
|
|
|
|
||||
|
Accounts payable, trade |
|
|
1,489 |
|
|
|
1,578 |
|
|
Accrued compensation and retirement costs |
|
|
112 |
|
|
|
119 |
|
|
Taxes, including income taxes |
|
|
34 |
|
|
|
43 |
|
|
Environmental remediation |
|
|
34 |
|
|
|
40 |
|
|
Operating lease liabilities |
|
|
36 |
|
|
|
34 |
|
|
Fair value of hedging instruments and derivatives |
|
|
13 |
|
|
|
7 |
|
|
Other current liabilities(1) |
|
|
181 |
|
|
|
150 |
|
|
Total current liabilities |
|
|
1,899 |
|
|
|
1,971 |
|
|
Long-term debt |
|
|
1,598 |
|
|
|
1,597 |
|
|
Accrued pension benefits |
|
|
582 |
|
|
|
586 |
|
|
Accrued other postretirement benefits |
|
|
295 |
|
|
|
302 |
|
|
Environmental remediation |
|
|
38 |
|
|
|
45 |
|
|
Operating lease liabilities |
|
|
78 |
|
|
|
83 |
|
|
Deferred income taxes |
|
|
6 |
|
|
|
3 |
|
|
Other noncurrent liabilities |
|
|
66 |
|
|
|
71 |
|
|
Total liabilities |
|
|
4,562 |
|
|
|
4,658 |
|
|
STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
|
Common stock |
|
|
1 |
|
|
|
1 |
|
|
Additional capital |
|
|
3,379 |
|
|
|
3,373 |
|
|
Accumulated deficit |
|
|
(650 |
) |
|
|
(734 |
) |
|
Treasury stock |
|
|
(347 |
) |
|
|
(346 |
) |
|
Accumulated other comprehensive loss |
|
|
(899 |
) |
|
|
(937 |
) |
|
Total stockholders’ equity |
|
|
1,484 |
|
|
|
1,357 |
|
|
Total liabilities and stockholders’ equity |
|
$ |
6,046 |
|
|
$ |
6,015 |
|
|
__________________ |
|
|
(1) |
At December 31, 2022, Arconic established both a liability of $61 (reported in Other current liabilities) for a potential settlement and a receivable of $53 (reported in Prepaid expenses and other current assets) for an anticipated insurance reimbursement of the potential settlement with respect to certain U.K. litigation in the Grenfell Tower matter. In the quarter ended March 31, 2023, the Company paid $43 for legal settlements applied against the liability and received insurance proceeds of $41. Also, in the quarter ended March 31, 2023, Arconic established both a liability of $74 (reported in Other current liabilities) for a settlement in principle and a receivable of $74 (reported in Prepaid expenses and other current assets) for an anticipated insurance reimbursement of the settlement in principle with respect to separate but related litigation in the Grenfell Tower matter (see footnote 1 to the Statement of Consolidated Operations included in this release). |
|
Arconic Corporation and subsidiaries |
||||||||||||
|
Statement of Consolidated Cash Flows (unaudited) |
||||||||||||
|
(dollars in millions) |
||||||||||||
|
|
|
Quarter ended |
||||||||||
|
|
|
June 30, |
|
March 31, |
|
June 30, |
||||||
|
2023 |
2023 |
2022 |
||||||||||
|
OPERATING ACTIVITIES |
|
|
|
|
|
|
||||||
|
Net income |
|
$ |
59 |
|
|
$ |
25 |
|
|
$ |
115 |
|
|
Adjustments to reconcile net income to cash provided from (used for) operations: |
|
|
|
|
|
|
||||||
|
Depreciation and amortization |
|
|
52 |
|
|
|
53 |
|
|
|
62 |
|
|
Deferred income taxes |
|
|
3 |
|
|
|
20 |
|
|
|
30 |
|
|
Restructuring and other charges(1) |
|
|
9 |
|
|
|
— |
|
|
|
2 |
|
|
Net periodic pension benefit cost |
|
|
17 |
|
|
|
17 |
|
|
|
18 |
|
|
Stock-based compensation |
|
|
12 |
|
|
|
6 |
|
|
|
8 |
|
|
Other |
|
|
1 |
|
|
|
22 |
|
|
|
(24 |
) |
|
Changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments: |
|
|
|
|
|
|
||||||
|
Decrease (Increase) in receivables(2) |
|
|
23 |
|
|
|
(107 |
) |
|
|
(31 |
) |
|
Decrease (Increase) in inventories |
|
|
116 |
|
|
|
(34 |
) |
|
|
(98 |
) |
|
(Increase) in prepaid expenses and other current assets |
|
|
(16 |
) |
|
|
(24 |
) |
|
|
(9 |
) |
|
(Decrease) Increase in accounts payable, trade |
|
|
(48 |
) |
|
|
5 |
|
|
|
80 |
|
|
(Decrease) Increase in accrued expenses |
|
|
(28 |
) |
|
|
(9 |
) |
|
|
11 |
|
|
(Decrease) Increase in taxes, including income taxes |
|
|
(4 |
) |
|
|
(22 |
) |
|
|
4 |
|
|
Pension contributions |
|
|
(9 |
) |
|
|
(10 |
) |
|
|
(9 |
) |
|
Decrease in noncurrent assets |
|
|
1 |
|
|
|
8 |
|
|
|
— |
|
|
Increase in noncurrent liabilities |
|
|
1 |
|
|
|
11 |
|
|
|
3 |
|
|
CASH PROVIDED FROM (USED FOR) OPERATIONS |
|
|
189 |
|
|
|
(39 |
) |
|
|
162 |
|
|
FINANCING ACTIVITIES |
|
|
|
|
|
|
||||||
|
Net change in short term borrowings (original maturities of three months or less)(3) |
|
|
(50 |
) |
|
|
50 |
|
|
|
(50 |
) |
|
Repurchases of common stock(4) |
|
|
— |
|
|
|
(1 |
) |
|
|
(37 |
) |
|
Other |
|
|
(12 |
) |
|
|
— |
|
|
|
1 |
|
|
CASH (USED FOR) PROVIDED FROM FINANCING ACTIVITIES |
|
|
(62 |
) |
|
|
49 |
|
|
|
(86 |
) |
|
INVESTING ACTIVITIES |
|
|
|
|
|
|
||||||
|
Capital expenditures |
|
|
(57 |
) |
|
|
(82 |
) |
|
|
(33 |
) |
|
Proceeds from the sale of assets and businesses |
|
|
— |
|
|
|
7 |
|
|
|
— |
|
|
CASH USED FOR INVESTING ACTIVITIES |
|
|
(57 |
) |
|
|
(75 |
) |
|
|
(33 |
) |
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS AND RESTRICTED CASH |
|
|
(1 |
) |
|
|
1 |
|
|
|
(1 |
) |
|
Net change in cash and cash equivalents and restricted cash |
|
|
69 |
|
|
|
(64 |
) |
|
|
42 |
|
|
Cash and cash equivalents and restricted cash at beginning of period(5) |
|
|
197 |
|
|
|
261 |
|
|
|
210 |
|
|
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD(5) |
|
|
266 |
|
|
|
197 |
|
|
|
252 |
|
|
__________________ |
|
|
(1) |
See footnote 2 to the Statement of Consolidated Operations for the quarter ended June 30, 2023 included in this release. |
|
(2) |
Arconic has two separate arrangements, each with a single financial institution, to sell certain customer receivables outright without recourse on a continuous basis. All such sales are at the Company’s discretion. The first arrangement, which was executed in January 2022, relates to certain of Arconic’s U.S. operations and automatically renews each year unless terminated in accordance with the provisions of the underlying purchase agreement. The second arrangement, which was executed in July 2022, relates to certain of the Company’s European operations. Under both arrangements, Arconic serves in an administrative capacity, including collection of the receivables from the respective customers and remittance of these cash collections to the respective financial institution. Accordingly, upon the sale of customer receivables to the financial institutions, the Company removes the underlying trade receivables from its Consolidated Balance Sheet and includes the reduction as a positive amount in the Decrease (Increase) in receivables line item within Operating Activities on its Statement of Consolidated Cash Flows. In the quarters ended June 30, 2023, March 31, 2023, and June 30, 2022, the Company sold customer receivables of $33, $151, and $329, respectively, and remitted cash to the financial institutions of $66, $116, and $267, respectively. |
|
(3) |
Arconic maintains a five-year credit agreement, dated May 13, 2020, with a syndicate of lenders named therein and Deutsche Bank AG New York Branch as administrative agent (the “ABL Credit Agreement”). The ABL Credit Agreement provides for a $1,200 senior secured asset-based revolving credit facility (the “ABL Credit Facility”) to be used, generally, for working capital or other general corporate purposes. In the quarters ended June 30, 2023 and March 31, 2023, the Company borrowed $25 and $150, respectively, and in the quarters ended June 30, 2023, March 31, 2023 and June 30, 2022, repaid $75, $100, and $50, respectively, under the ABL Credit Facility. |
|
(4) |
On November 16, 2022, Arconic announced that its Board of Directors approved a new share repurchase program authorizing the Company to repurchase shares of its outstanding common stock up to an aggregate transactional value of $200 over a two-year period expiring November 17, 2024. In the quarter ended March 31, 2023, the Company repurchased 35,615 shares of its common stock under this program. |
|
|
In the quarter ended June 30, 2022, the Company repurchased 1,324,027 shares of its common stock under its previous share repurchase program, which was authorized in May 2021 and completed in August 2022. Cumulatively, the Company repurchased 9,776,177 shares of its common stock for $300 under this program. In connection with the authorization of the new program, Arconic’s previous repurchase program was terminated. |
|
(5) |
Cash and cash equivalents and restricted cash at beginning of period for all periods presented and Cash and cash equivalents and restricted cash at end of period for all periods presented includes Restricted cash of less than $0.03. |
|
Arconic Corporation and subsidiaries |
||||||||||||
|
Segment Adjusted EBITDA Reconciliation (unaudited) |
||||||||||||
|
(in millions) |
||||||||||||
|
|
|
Quarter ended |
||||||||||
|
|
|
June 30, |
|
March 31, |
|
June 30, |
||||||
|
2023 |
2023 |
2022 |
||||||||||
|
Total Segment Adjusted EBITDA(1) |
|
$ |
210 |
|
|
$ |
167 |
|
|
$ |
215 |
|
|
Unallocated amounts: |
|
|
|
|
|
|
||||||
|
Corporate expenses(2) |
|
|
(11 |
) |
|
|
(9 |
) |
|
|
(10 |
) |
|
Stock-based compensation expense |
|
|
(12 |
) |
|
|
(6 |
) |
|
|
(8 |
) |
|
Metal price lag(3) |
|
|
(20 |
) |
|
|
— |
|
|
|
30 |
|
|
Unrealized gains (losses) on mark-to-market hedging instruments and derivatives |
|
|
18 |
|
|
|
(20 |
) |
|
|
21 |
|
|
Provision for depreciation and amortization |
|
|
(52 |
) |
|
|
(53 |
) |
|
|
(62 |
) |
|
Restructuring and other charges(4) |
|
|
(9 |
) |
|
|
— |
|
|
|
(2 |
) |
|
Other(5) |
|
|
(7 |
) |
|
|
(8 |
) |
|
|
(40 |
) |
|
Operating income |
|
|
117 |
|
|
|
71 |
|
|
|
144 |
|
|
Interest expense |
|
|
(25 |
) |
|
|
(25 |
) |
|
|
(26 |
) |
|
Other expenses, net(6) |
|
|
(16 |
) |
|
|
(11 |
) |
|
|
35 |
|
|
Provision for income taxes |
|
|
(17 |
) |
|
|
(10 |
) |
|
|
(38 |
) |
|
Net income attributable to noncontrolling interest(7) |
|
|
— |
|
|
|
— |
|
|
|
(1 |
) |
|
Consolidated net income attributable to Arconic Corporation |
|
$ |
59 |
|
|
$ |
25 |
|
|
$ |
114 |
|
Contacts
Investor Contact
Shane Rourke
(412) 315-2984
[email protected]
Media Contact
Tracie Gliozzi
(412) 992-2525
[email protected]
